GlobeImmune Inc (OTCMKTS:GBIM)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.19 and traded as low as $0.15. GlobeImmune shares last traded at $0.18, with a volume of 800 shares trading hands.
The business has a fifty day moving average of $0.25 and a 200 day moving average of $0.19.
About GlobeImmune (OTCMKTS:GBIM)
GlobeImmune, Inc, a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform. Its product candidate includes GS-4774, which is in Phase 2 trials for the treatment of patients with chronically infected with hepatitis B virus, as well as with oral antiviral suppressive therapy.
Featured Article: Does a trade war provide a risk to the global economy?
Receive News & Ratings for GlobeImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlobeImmune and related companies with MarketBeat.com's FREE daily email newsletter.